2022
DOI: 10.1016/bs.pmbts.2021.07.015
|View full text |Cite
|
Sign up to set email alerts
|

Paper-microfluidic signal-enhanced immunoassays

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 69 publications
0
4
0
Order By: Relevance
“…Lateral Flow Assays (LFAs) have emerged as valuable paper-microfluidic tools for point-of-care (POC) diagnostics, offering a quick, economical, and user-friendly method to detect the presence of analytes in complex samples [1][2][3][4][5][6][7][8] . Primarily known for their application in medical diagnostics, environmental monitoring, and food safety, LFAs have gained significant attention for their potential in point-of-care testing, especially in resource-limited settings 2,4,7,9,10 . Accurate and reproducible quantification and interpretation of the assay results is crucial for reliable diagnosis.…”
Section: Introductionmentioning
confidence: 99%
“…Lateral Flow Assays (LFAs) have emerged as valuable paper-microfluidic tools for point-of-care (POC) diagnostics, offering a quick, economical, and user-friendly method to detect the presence of analytes in complex samples [1][2][3][4][5][6][7][8] . Primarily known for their application in medical diagnostics, environmental monitoring, and food safety, LFAs have gained significant attention for their potential in point-of-care testing, especially in resource-limited settings 2,4,7,9,10 . Accurate and reproducible quantification and interpretation of the assay results is crucial for reliable diagnosis.…”
Section: Introductionmentioning
confidence: 99%
“…This blocking reduces the binding of the label in the analytical zone and makes reliable serodiagnostics difficult at low contents of specific antibodies [16,17]. The use of additional stages of the assay to enhance the recorded signal is possible [18,19], but it deprives LFIA of its main advantages in rapidity and easy implementation. This limitation can be overcome in various ways.…”
Section: Introductionmentioning
confidence: 99%
“…Lateral flow immunoassays (LFAs) have revolu onized point-of-care diagnos cs due to their simplicity, speed, and costeffec veness. [1][2][3] However, achieving high sensi vity remains a challenge, par cularly when detec ng low analyte concentra ons. Conven onal LFAs u lizing gold nanopar cles (AuNPs) as reporters have limita ons in sensi vity, o en falling short compared to more sensi ve techniques such as enzyme-linked immunosorbent assays (ELISA) or polymerase chain reac on (PCR) [1] .…”
Section: Introduc Onmentioning
confidence: 99%
“…Thus, there is a need for innova ve strategies to enhance the sensi vity of LFAs.One approach to improve LFA sensi vity is the use of enzyma c LFAs, in which the detec on an body is conjugated to an enzyme, such as horseradish peroxidase (HRP). Upon binding to the target analyte, the enzyme-labelled an body generates a detectable signal through a cataly c reac on [2][3][4] . This enzyma c amplifica on mechanism provides a means to achieve higher sensi vity in LFAs by increasing the signal output and facilita ng the detec on of low analyte concentra ons.The present work focuses on developing enzyma cally enhanced lateral flow immunoassays capable of detec ng sub-ng/mL concentra ons of an gens.…”
mentioning
confidence: 99%